There is a growing feeling in the United Kingdom that the problem of hypertension in pregnancy has largely been resolved by antenatal care and present methods of management. It is true that the incidence of the very severe forms of the disease and eclampsia has fallen dramatically, but the condition still heads the list in the causation of maternal death, and still makes the largest contribution to antenatal hospital admission. Furthermore, it is also true to say that in many countries eclampsia continues to be a common and important problem.
Is pre-eclampsia a disease at all, or does it represent an aberration of the normal adaptive mechanism of pregnancy? After all, about 10% of all women develop hypertension during pregnancy having started the pregnancy with a normal blood pressure; and although there is published evidence to show that the higher the diastolic blood pressure and the earlier the pregnancy, the worse the prognosis for the fetus, the critical marker for both fetal and maternal risk appears to be the appearance of proteinuria. For example, an examination of perinatal mortality over two years in the obstetric population at the Nottingham City Hospital in women who developed hypertension during pregnancy, with and without proteinuria, is shown in Table 1 . What is surprising about the figures is not the high mortality rate in the proteinuric group, but the exceptionally low perinatal losses in the hypertensive women. One would like to believe that our excellent management of bed rest and appropriately timed induction has been the cause of this success, but a more cynical and unbiased observer might also say that mild hypertension, like mild oedema, appears to have a beneficial effect on fetal survival. Indeed, provided the elevation of maternal blood pressure is not associated with vasoconstriction in the uterine vascular tree, the increase in perfusion pressure associated with hypertension is likely to be beneficial to fetal growth and development.
In general terms, there appear to be two populations within pregnancy hypertension and here one excludes those women who have some underlying renal disease or a non-pregnancy related cause for their hypertension. One group develops hypertension in late pregnancy and this does not appear to progress to the detriment of the system; the other proceeds on to develop the classical manifestations of renal and placental involvement with risk to both mother and fetus. The problem at the present time is that it is not possible to differentiate these two groups with any certainty until the pregnancy has ended.
Common mechanisms in pre-eclampsia Any common theme to explain pre-eclampsia must take into account a bewildering variety of apparently predisposing factors. For example, due consideration must be given to the higher incidence in women having their first child. There is also evidence which has been known for years of dietetic factors, familial trends, the influence of race and of geographic location. However, there is a need to differentiate between predisposing factors and the actual mechanism by which the elevation of blood pressure occurs with all the sequelae that result from vasospasm and disseminated intravascular coagulation. Page (1972) summarized this concept in an eloquent paper. He described an 'inner vicious circle' which tended to be selfperpetuating in a cascade of events which is only broken by the termination of the pregnancy. Thus, a reduction in the uteroplacental circulation associated with vasoconstriction resulted in damage to the placenta, the release of trophoblast into the circulation precipitating disseminated intravascular coagulation, fibrin deposition, glomerular endothelial lesions, reduced glomerular filtration rate, sodium retention and intracellular sodium shift with reduction in plasma volume and further reduction in placental perfusion. The importance of the paradoxical reduction in plasma volume and the hazards of diuretic therapy in this situation have now been extensively investigated by Campbell & MacGillivray (1975) . Page (1972) also described an outer circle of predisposing factors which might influence this situation, including sodium load, chronic renal and hypertensive diseases and posture, and to these one would add other factors including diet, genetic constitution and immunological factors. These factors may break into the chain at various points, thus precipitating a sequence of events which affects every system in the body.
Central nucleus of biochemical changes in pre-eclampsia Perhaps there should be a nucleus within the inner circle which constitutes the essential biochemical mechanism for these changes. The central debate about this nucleus tends now to concentrate itself on three major aspects. Firstly, it is important to remember that the elevation of blood pressure is the direct result of arteriolar vasospasm which, in itself, constitutes a manifestation of an imbalance between vasoconstrictor and vasodilator tone. Secondly, there is no doubt that the pathological manifestations of the condition are the direct result of disseminated intravascular coagulation. Thirdly, there is an increasing body of evidence that immunological incompatibility plays an important role, although the mechanism by which this affects the blood pressure and the coagulation change remains obscure.
This paper will principally discuss the regulation of vasomotor tone as a central theme in this debate simply because one believes that it lies at the heart of the problem and because our own work in Nottingham for the last eight years has been directed at trying to understand this mechanism. However, it would be inappropriate not to mention briefly some of the exciting observations that have recently emerged in the other two fields.
Immunological factors There has been a notion for many years that pre-eclampsia might result from excessive fetomaternal incompatibility. Stevenson et al. (1976) claimed to demonstrate that a lower incidence of pre-eclampsia occurred in consanguinous marriages, a higher incidence of preeclampsia in dizygous than monozygous twins, and in women with a male rather than a female fetus. Their data have not been confirmed by other workers. Studies on blood groups and HLA types have failed to produce any consistent evidence of immunological imbalance. Recently, Redman and his colleagues (1978) in Oxford found a highly significant excess of apparent maternal HLA homozygosity. It was more pronounced at the B than at the A locus and was correlated with the severity of the condition. The hypothesis has been suggested that this could indicate homozygosity for recessive maternal immune response genes linked to HLA.
Indices of cell-mediated immune response have also been shown to alter in severe eclampsia. Need et al. (1976) in Leeds have demonstrated a significant reduction in lymphocyte response to phytohaemagglutinin stimulation in pre-eclampsia, but whether these changes are primary or secondary remains an unanswered question.
Disseminated intravascular coagulation
The development of fibrin deposition within the small blood vessels in eclampsia has been known since 1893 when Schmorl noted thrombosis in capillaries of women dying from eclampsia. Many studies have now shown raised blood levels of fibrin degradation products in severe pre-eclampsia and eclampsia. It seems likely that fibrin deposition results from both increased fibrin production and deposition, and impaired removal of fibrin by reduced fibrinolytic activity, and there can be no doubt that the coagulation changes playa major part in the pathology of the disease. The fundamental question is whether these changes are primary or secondary. Condie & Ogston (1976) demonstrated a loss of fibrinolytic activity in early pregnancy in women who later developed pre-eclampsia. However, the study of Howie et al. (1976) showed that changes in Factor VIII, platelet count and serum fibrin degradation product tend to parallel the severity of pre-eclampsia. Thus, it seems likely that the coagulation changes follow rather than precede the vascular changes.
Vasomotor changes
The third group ofchanges are those that relate to vascular control. For many years it has been known that hypertension arising during pregnancy is directly related to vasoconstriction of the arteriolar bed, particularly in the uterus and kidney. Now, there is a vast array of potential vasoactive peptides which might account for the humoral induction of vasospasm. Increased activity of the sympathetic nervous system and increased catecholamine synthesis may provide an explanation and, indeed, there is some evidence of raised catecholamine levels in pre-eclampsia. However, our own work on the use of a combined alpha-and beta-blocker, labetalol, in severe pre-eclampsia suggests that this is not the case. Lamming & Symonds (1979) reported the effect of the infusion of labetalol into a woman with severe pre-eclampsia. An immediate response was obtained with a fall in blood pressure. However, the following day a sharp rise in blood pressure occurred again and on this occasion, despite massive doses of labetalol, the blood pressure was not controlled until delivery was effected.
The possible involvement of the renin-angiotensin system has always held certain attractions. Firstly, angiotensin II is the most potent vasoconstrictor peptide known and, secondly, the enzyme renin which produces angiotensin II is synthesized both in the kidney and the uterus.
At a simple level, if this system is involved one would expect a relationship between blood pressure and circulating levels of angiotensin II (All). Symonds et al. (1975) studied the relationship between diastolic blood pressure and plasma All measured in late pregnancy in over 50 primigravidae. There was a direct and significant relationship, although not all hypertensive women showed raised levels of angiotensin II. The work of Weir et al. (1973) showed suppressed levels of All in early severe hypertensive diseases. We do, however, believe from our studies of a large series of women with severe pre-eclampsia that All levels are consistently raised. If one looks at the fetal side of the picture there is evidence to show that in infants delivered to women who have developed pre-eclampsia, the levels of All in the cord venous blood are significantly elevated above the levels seen in a normotensive population (Broughton Pipkin & Symonds 1976) .
Furthermore, in a study of All levels in peripheral venous blood and uterine venous blood collected at elective caesarean section in severely hypertensive women and a matched control group of normotensive women, levels of All in the uterine vein exceeded peripheral levels in the hypertensive group, but the reverse was true in the normotensive group. Thus, our evidence suggests that All is produced in the placental bed and released into both the fetal and maternal circulation. However, equally important in this situation is the actual sensitivity of the vascular tree to angiotensin II.
Vascular sensitivity
Normal pregnancy is associated with a two-fold increase in the activity of the renin-angiotensin system and yet blood pressure does not rise; it is known that the sensititivity to infused All is markedly reduced. Gant et of. (1977) have shown that sensitivity to All increases in pre-eclampsia and that this loss of resistance antedates the development of hypertension.
Several groups, including our own, have been interested in the mechanism that blocks the normal response to All and it now seems likely that tissue active local vasodilator prostaglandins may be responsible. O'Brien et of. (1977) investigated the effect of infusing, prostaglandin (PG) E 2 on the response to angiotensin II, as measured by a rise in blood pressure in pregnant rabbits. Although the blood pressure does not fall in response to an infusion of PGE 2 , the response to infused All is reduced by about 50% as a result of the PGE 2 . The same effect was not observed with PGF k O'Brien & Broughton Pipkin (1979) also observed the effect of dietary deprivation of' essential fatty acids on sensitivity to angiotensin II on the basis that if one removed the precursors for the formation of prostaglandins, the sensitivity to All should be increased. This study, performed on New Zealand white rabbitts, showed that the animals deprived of essential fatty acids throughout pregnancy were significantly more sensitive to infused All in late pregnancy than the control animals. This does not seem to be a phenomenon of rabbits: Broughton Pipkin, Hunter and Turner (in preparation) have recently completed a study on sensitivity to All following PGE 2 infusion in human subjects in mid-trimester pregnancies and have demonstrated an identical response, with impaired response to infused All following PGE 2 • Franklin et al. (1974) have shown that the infusion of All into the uterine circulation of experimental animals promotes the release of vasodilator prostaglandin (E series) into the uterine venous circulation and may result in a paradoxical improvement in placental bed blood flow.
Thus, our hypothesis would suggest the following: in normal pregnancy, the fetus can regulate placental bed blood flow by local and distal effects in the maternal vascular tree. The local release of All in the placental bed would have the effect of promoting uteroplacental blood flow by stimulating the release of local vasodilator prostaglandins, whilst the release of All into the maternal circulation would elevate maternal blood pressure and hence increase the perfusion pressure in the placental bed. Such a system would act to the benefit of the fetus. If the production of All becomes excessive, or the production of vasodilator prostaglandin defective, the vasoconstriction would occur in the uteroplacental circulation, maternal blood pressure would rise and the whole cascade of Page's inner vicious circle would be precipitated. It should be possible to blockade this sequence of events by blocking the production ofAll. The drug captopril acts by inhibition of angiotensin converting enzyme and should achieve this effect. However, Broughton Pipkin et al. (1980) have recently infused this drug into two species -the sheep and the rabbit -and demonstrated disastrous consequences for the fetus (Table 2) . Four out of five fetal lambs died and nearly 40% of the rabbit fetuses succumbed. It seems likely that we will need to look towards promoting increased prostaglandin synthesis, as the fetus appears to be dependent on All for survival. One is well aware of the dangers of projecting hypotheses, and it is an activity that one inherently dislikes. No doubt this hypothesis will be overtaken by others and is, no doubt, a gross over-simplification. The late Percy Malpas (1953) once said that 'both simple and expedient views of causation are inadequate for biological inquiries. Within an integrated living body, there is no remote causation, merely a succession of dynamic patterns'.
